Squarepoint’s Aehr Test Systems AEHR Stock Holding History

Squarepoint’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	+2,700	New	+$247K	﹤0.01%	3916
2025 Q1	–	Sell	-22,100	Closed	-$368K	–	4493
2024 Q4	$368K	Buy	+22,100	New	+$295K	﹤0.01%	4001
2024 Q3	–	Sell	-76,000	Closed	-$849K	–	4053
2024 Q2	$849K	Sell	76,000 -96,100	-56%	-$1.12M	﹤0.01%	2680
2024 Q1	$2.13M	Buy	+172,100	New	+$2.87M	﹤0.01%	2038

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Squarepoint's AEHR Position: Q2 2026 in Review

Squarepoint sold out of Aehr Test Systems (AEHR) in Q2 2026, closing a stake of 23,586 shares — an estimated $2.16M sold.

Squarepoint first reported a position in AEHR in Q3 2017 and held it in 11 quarters. The position peaked at $3.04M in Q1 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Squarepoint reported no remaining Aehr Test Systems position as of Q2 2026 after selling out during the quarter.
Squarepoint sold 23,586 Aehr Test Systems shares in Q2 2026, an estimated $2.16M.
Squarepoint first reported a position in Aehr Test Systems in Q3 2017 and held it in 11 quarters.
Squarepoint's Aehr Test Systems position peaked at $3.04M in Q1 2023.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.